---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-107725"
form_type: "8-K"
ticker: "RIGL"
cik: "0001034842"
company_name: "RIGEL PHARMACEUTICALS INC"
filed_at: "2022-10-11T23:59:59+00:00"
generated_at: "2026-06-23T04:13:45.452850+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Rigel drops wAIHA sNDA after FDA feedback; cuts 16% workforce, 30 jobs

## Summary
- FDA guidance on FORWARD Phase 3 re-analysis leads Rigel to halt sNDA for fostamatinib in wAIHA.
- Workforce reduction of 16% (30 positions) primarily in development and admin; completion by Jan 31, 2023.
- One-time cash severance charge of ~$1.5M in Q4 2022; expects $7-8M annual savings from 2023.
- General counsel Dolly Vance retires effective Oct 11, 2022; remains as employee through Nov 30, 2022.

## SEC filing metadata
- accession: 0001104659-22-107725
- form_type: 8-K
- ticker: RIGL
- cik: 0001034842
- company_name: RIGEL PHARMACEUTICALS INC
- filed_at: 2022-10-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.05, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1034842/000110465922107725/0001104659-22-107725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1034842/000110465922107725/tm2227881d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-107725
- JSON: https://secwatch.observer/filing/0001104659-22-107725.json
- Plain text: https://secwatch.observer/filing/0001104659-22-107725.txt

## Key facts
- Executive change
  Dolly A. Vance retired as general counsel at RIGEL PHARMACEUTICALS INC.
  - Action: retired
  - Role: general counsel
  source text: On October 11, 2022, Dolly A. Vance provided notice of her retirement from her position as general counsel, executive vice president, corporate affairs, and corporate secretary of Rigel, effective the date of this current report.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1034842/000110465922107725/0001104659-22-107725-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.